Roivant Sciences Ltd.
ROIVNasdaqCIK 1635088HealthcareFiscal year ends Mar 31
Reports and events: 145 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2107:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-040332 |
| 2026-10-0521:02 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-26-038693 |
| 2026-09-1807:14 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001635088-26-000095 |
| 2026-09-0809:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-035859 |
| 2026-08-2816:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-034854 |
| 2026-08-2717:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-034735 |
| 2026-08-0607:28 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001635088-26-000090 |
| 2026-08-0607:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001635088-26-000088 |
| 2026-07-2907:00 ET | DEF 14A | Proxy statementPeriod 2026-09-16 | 0001140361-26-029955 |
| 2026-05-2007:17 ET | 10-K | Annual reportPeriod 2026-03-31 | 0001635088-26-000061 |
| 2026-05-2007:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001635088-26-000060 |
| 2026-04-0207:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-012885 |
| 2026-03-2308:44 ET | 8-K/A | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-010656 |
| 2026-03-0316:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-007548 |
| 2026-03-0307:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-007447 |
| 2026-02-0607:31 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001635088-26-000011 |
| 2026-02-0607:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001635088-26-000009 |
| 2025-12-1107:46 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-045204 |
| 2025-11-1007:25 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001635088-25-000016 |
| 2025-11-1007:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-041269 |
| 2025-09-1707:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-035190 |
| 2025-09-1117:00 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-25-034711 |
| 2025-09-0313:38 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-033767 |
| 2025-08-1107:31 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001140361-25-030001 |
| 2025-08-1107:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-029998 |
| 2025-07-2916:58 ET | DEF 14A | Proxy statementPeriod 2025-09-10 | 0001140361-25-027846 |
| 2025-06-2507:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-023553 |
| 2025-05-2907:53 ET | 10-K | Annual reportPeriod 2025-03-31 | 0001140361-25-020715 |
| 2025-05-2907:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-020713 |
| 2025-04-2107:42 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-014642 |
| 2025-03-2016:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-009696 |
| 2025-03-1907:51 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-009362 |
| 2025-02-2507:19 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-25-005770 |
| 2025-02-2116:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-005445 |
| 2025-02-1817:21 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-25-005025 |
| 2025-02-1010:16 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001140361-25-003661 |
| 2025-02-1007:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-003639 |
| 2024-12-0307:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-048238 |
| 2024-11-1207:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001140361-24-046019 |
| 2024-11-1207:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-046015 |
| 2024-10-2816:30 ET | 8-K | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-044434 |
| 2024-09-2316:34 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-24-041663 |
| 2024-09-1807:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-041344 |
| 2024-09-1617:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-24-041188 |
| 2024-09-1007:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-040650 |
| 2024-09-0907:53 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-040507 |
| 2024-08-0916:32 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001140361-24-036642 |
| 2024-08-0807:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-036281 |
| 2024-07-2616:59 ET | DEF 14A | Proxy statementPeriod 2024-09-10 | 0001140361-24-034423 |
| 2024-05-3016:46 ET | 10-K | Annual reportPeriod 2024-03-31 | 0001140361-24-028145 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 18:30 ET. Listed shows no prices and gives no investment advice.